News for Industry
Harvard Researchers Identify Potential Stem Cell Treatment for ALS (Stem Cell Freak)
(Boston, MA) Researchers present a series of studies aimed at developing an effective treatment for amyotrophic lateral sclerosis (ALS).
Genetically Pliable Stem Cells Could Become the ‘New Lab Mouse’ (MSKCC)
(New York, NY) Memorial Sloan-Kettering researchers develop a new technique to study complex genetic conditions including cancers using human pluripotent stem cells.
Team Reveals Molecular Competition Drives Adult Stem Cells to Specialize (Phys)
(Kansas City, MO) Adult organisms harbor adult stem cells some of which renew and others which differentiate differentiate.
Cytori Halts Stem Cell Study Due to Adverse Events (Business Week)
(San Diego, CA) Cytori therapeutics halted trials of stem cell therapy for heart failure after 3 patients developed blood flow problems.
International Stem Cell Corp Launches Stroke Program With Tulane (CNN)
(Carlsbad, CA) International Stem Cell Corporation launched a new stroke program in collaboration with Tulane University to examine neural stem cell transplantation in a preclinical rodent model.
Implanted Induced Neuron Stem Cells (iNSC) Become Part of the Brain (WWWEN)
(Luxemberg City, Luxemberg) Scientists have grafted neurons reprogrammed from skin cells into the brains of mice and have demonstrated long-term stability.
Cynata Therapeutics Inks Contract for Stem Cell Studies with WuXi AppTec (Proactive Investors)
(St. Paul, MN) Australia-based Cynata Therapeutics signed an agreement with Wuxi AppTech to conduct pre-clinical safety studies with a new stem cell technology.
Scientists Announce Technique to Create Red & White Blood Cells from PSCs (Medical XPress)
(Madison, WI) University of Wisconsin researchers have reported the discovery of 2 genetic programs responsible for turning pluripotent stem cells into red blood cells or an variety of white blood cells.
BioTime, Inc. Announces 14 New Patents For iPSC Applications (WSJ)
(Alameda, CA) BioTime announced the issuance of 14 new patents to add to the largest known patent estate under one corporate umbrella in the field of pluripotent stem cell technology.